June Sherie Almenoff - Nov 17, 2025 Form 4 Insider Report for TENAX THERAPEUTICS, INC. (TENX)

Role
Director
Signature
/s/ S. Halle Vakani, as Attorney-in-Fact
Stock symbol
TENX
Transactions as of
Nov 17, 2025
Transactions value $
$14,945
Form type
4
Date filed
11/19/2025, 06:43 PM
Previous filing
Jul 3, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Almenoff June Sherie Director 101 GLEN LENNOX DRIVE SUITE 300, CHAPEL HILL /s/ S. Halle Vakani, as Attorney-in-Fact 2025-11-19 0001492647
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TENX Common Stock Purchase $665 +93 $7.15 93 Nov 17, 2025 Direct
transaction TENX Common Stock Purchase $14.3K +1.9K +2043.01% $7.52 1.99K Nov 18, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TENX Stock Option (right to buy) 4 Nov 17, 2025 Common Stock 4 $3,200.00 Direct
holding TENX Stock Option (right to buy) 4 Nov 17, 2025 Common Stock 4 $992.00 Direct
holding TENX Stock Option (right to buy) 100K Nov 17, 2025 Common Stock 100K $5.94 Direct
holding TENX Stock Option (right to buy) 80K Nov 17, 2025 Common Stock 80K $5.75 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $7.45 to $7.70. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.